Risk of bias assessment using the Consolidated Health Economic Evaluation Reporting Standards statement
Study | Item | |||||||||||||||||||||
1. Title | 2. Abstract | 3. Background and objectives | 4. Target population and subgroups | 5. Setting and location | 6. Study perspective | 7. Comparators | 8. Time horizon | 9. Discount rate | 10. Choice of health outcomes | 11. Measurement of effectiveness | 12. Measurement and valuation of preference-based outcomes | 13. Estimating recourses and costs | 14. Currency, price date and conversion | 17. Analytical methods | 19. Incremental costs and outcomes | 20. Characterising uncertainty | 21. Characterising heterogeneity | 22. Study findings, limitations, generalisability and current knowledge | 23. Source of funding | 24. Conflicts of interest | Score (0/21) | |
Aboagye et al 39 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | N/A | Yes | Yes | Yes | 18 |
Bello et al 40 | No | No | Yes | Yes | Yes | No | Yes | No | N/A | Yes | Yes | N/A | No | No | No | No | No | N/A | No | Yes | Yes | 8 |
Bosmans et al 34 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 19 |
Carr et al 41 | No | No | No | Yes | Yes | No | Yes | Yes | N/A | Yes | Yes | No | No | No | Yes | No | No | N/A | No | No | No | 7 |
Cherkin et al 42 | No | No | No | Yes | Yes | No | Yes | Yes | No | Yes | Yes | N/A | No | Yes | No | No | No | N/A | Yes | Yes | No | 9 |
Chuang et al 43 | No | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 18 |
Critchley et al 44 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | No | No | No | Yes | Yes | Yes | Yes | 16 |
van Dongen et al 38 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 20 |
Henchoz et al 45 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | No | Yes | No | Yes | Yes | Yes | No | N/A | Yes | No | No | 14 |
Hlobil et al 46 | No | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | N/A | Yes | No | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 15 |
Hollinghurst et al 47 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 20 |
Hurley et al 48 | No | No | Yes | Yes | Yes | No | Yes | No | N/A | Yes | Yes | No | Yes | No | No | Yes | No | N/A | No | Yes | Yes | 10 |
Korthals-de Bos et al 35 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | No | Yes | No | Yes | Yes | Yes | Yes | No | Yes | Yes | 16 |
Leininger et al 36 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 20 |
Manca et al 55 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | No | Yes | Yes | 18 |
van der Roer et al 53 | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | N/A | Yes | Yes | Yes | 19 |
Rosenfeld et al 37 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | N/A | No | No | No | No | No | N/A | No | Yes | Yes | 11 |
Seferlis et al 49 | Yes | No | Yes | Yes | Yes | No | Yes | Yes | N/A | Yes | Yes | N/A | No | Yes | No | No | No | N/A | No | Yes | No | 10 |
Smeets et al 50 | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No | 18 |
Torstensen et al 52 | Yes | No | Yes | Yes | Yes | No | Yes | Yes | No | Yes | Yes | N/A | No | No | No | No | No | N/A | No | Yes | No | 9 |
UK BEAM51 | Yes | Yes | No | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | 20 |
Wright et al 54 | No | No | Yes | Yes | Yes | No | Yes | Yes | N/A | Yes | Yes | N/A | No | No | No | No | No | N/A | No | Yes | Yes | 9 |